Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Lieske H Schrijver"'
Autor:
Lieske H Schrijver, Thea M Mooij, Anouk Pijpe, Gabe S Sonke, Marian J E Mourits, Nadine Andrieu, Antonis C Antoniou, Douglas F Easton, Christoph Engel, David Goldgar, Esther M John, Karin Kast, Roger L Milne, Håkan Olsson, Kelly-Anne Phillips, Mary Beth Terry, John L Hopper, Flora E van Leeuwen, Matti A Rookus
Publikováno v:
Journal of the National Cancer Institute, 114(4), 540-552. Oxford University Press
J Natl Cancer Inst
Schrijver, L H, Mooij, T M, Pijpe, A, Sonke, G S, Mourits, M J E, Andrieu, N, Antoniou, A C, Easton, D F, Engel, C, Goldgar, D, John, E M, Kast, K, Milne, R L, Olsson, H K, Phillips, K-A, Terry, M B, Hopper, J L, van Leeuwen, F E & Rookus, M A 2022, ' Oral Contraceptive Use in BRCA1 and BRCA2 Mutation Carriers : Absolute Cancer Risks and Benefits ', Journal of the National Cancer Institute, vol. 114, no. 4, pp. 540-552 . https://doi.org/10.1093/jnci/djac004
J Natl Cancer Inst
Schrijver, L H, Mooij, T M, Pijpe, A, Sonke, G S, Mourits, M J E, Andrieu, N, Antoniou, A C, Easton, D F, Engel, C, Goldgar, D, John, E M, Kast, K, Milne, R L, Olsson, H K, Phillips, K-A, Terry, M B, Hopper, J L, van Leeuwen, F E & Rookus, M A 2022, ' Oral Contraceptive Use in BRCA1 and BRCA2 Mutation Carriers : Absolute Cancer Risks and Benefits ', Journal of the National Cancer Institute, vol. 114, no. 4, pp. 540-552 . https://doi.org/10.1093/jnci/djac004
Background To help BRCA1 and 2 mutation carriers make informed decisions regarding use of combined-type oral contraceptive preparation (COCP), absolute risk-benefit estimates are needed for COCP-associated cancer. Methods For a hypothetical cohort of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e5d8adf3cea7d3c8e77444acd57bd6e
https://doi.org/10.1093/jnci/djac004
https://doi.org/10.1093/jnci/djac004
Autor:
Lieske H. Schrijver, Antonis C. Antoniou, Håkan Olsson, Thea M. Mooij, Marie-José Roos-Blom, Leyla Azarang, Julian Adlard, Munaza Ahmed, Daniel Barrowdale, Rosemarie Davidson, Alan Donaldson, Ros Eeles, D. Gareth Evans, Debra Frost, Alex Henderson, Louise Izatt, Kai-Ren Ong, Valérie Bonadona, Isabelle Coupier, Laurence Faivre, Jean-Pierre Fricker, Paul Gesta, Klaartje van Engelen, Agnes Jager, Fred H. Menko, Marian J.E. Mourits, Christian F. Singer, Yen Y. Tan, Lenka Foretova, Marie Navratilova, Rita K. Schmutzler, Carolina Ellberg, Anne-Marie Gerdes, Trinidad Caldes, Jacques Simard, Edith Olah, Anna Jakubowska, Johanna Rantala, Ana Osorio, John L. Hopper, Kelly-Anne Phillips, Roger L. Milne, Mary Beth Terry, Catherine Noguès, Christoph Engel, Karin Kast, David E. Goldgar, Flora E. van Leeuwen, Douglas F. Easton, Nadine Andrieu, Matti A. Rookus, Lilian Laborde, Pauline Pontois, Emanuelle Breysse, Margot Berline, Dominique Stoppa-Lyonnet, Marion Gauthier-Villars, Bruno Buecher, Chrystelle Colas, Olivier Caron, Emmanuelle Mouret-Fourme, Claire Saule, Christine Lasset, Sophie Dussard, Pascaline Berthet, Elisabeth Luporsi, Véronique Mari, Laurence Gladieff, Stéphanie Chieze-Valéro, Jessica Moretta, Hagay Sobol, François Eisinger, Cornel Popovici, Michel Longy, Louise Grivelli, Florent Soubrier, Patrick Benusiglio, Pascal Pujol, Carole Corsini, Marie-Emmanuelle Morin-Meschin, Alain Lortholary, Claude Adenis, Audrey Maillez, Tan Dat Nguyen, Capucine Delnatte, Caroline Abadie, Julie Tinat, Isabelle Tennevet, Christine Maugard, Yves-Jean Bignon, Mathilde Gay Bellile, Clotilde Penet, Hélène Dreyfus, Odile Cohen-Haguenauer, Brigitte Gilbert, Laurence Venat-Bouvet, Dominique Leroux, Clémentine Legrand, Hélène Zattara-Cannoni, Valérie Layet, Elodie Lacaze, Sandra Fert-Ferrer, Odile Bera, Brigitte Gilbert-Dussardier, David Tougeron, Hakima Lallaoui, M.A. Rookus, F.B.L. Hogervorst, F.E. van Leeuwen, M.A. Adank, M.K. Schmidt, D.J. Jenner, J.M. Collée, A.M.W. van den Ouweland, M.J. Hooning, I.A. Boere, C.J. van Asperen, P. Devilee, R.B. van der Luijt, T.C.T.E.F. van Cronenburg, M.R. Wevers, A.R. Mensenkamp, M.G.E.M. Ausems, M.J. Koudijs, I. van de Beek, K. van Engelen, J.J.P. Gille, E.B. Gómez García, M.J. Blok, M. de Boer, L.P.V. Berger, A.H. van der Hout, M.J.E. Mourits, G.H. de Bock, S. Siesling, J. Verloop, E.C. van den Broek
Publikováno v:
American Journal of Obstetrics and Gynecology, 225(1), 51.e1-51.e17. MOSBY-ELSEVIER
Epidemiological Study of Familial Breast Cancer, Gene Etude Prospective Sein Ovaire Sein, Hereditary Breast and Ovarian Cancer Research Group Netherlands, and International BRCA1/2 Carrier Cohort Study 2021, ' Oral contraceptive use and ovarian cancer risk for BRCA1/2 mutation carriers : an international cohort study ', American Journal of Obstetrics and Gynecology, vol. 225, no. 1, pp. 51.e1-51.e17 . https://doi.org/10.1016/j.ajog.2021.01.014
American Journal of Obstetrics and Gynecology, 225, 51.e1-51.e17
American Journal of Obstetrics and Gynecology, 225(1), 51.e1-51.e17. Mosby Inc.
American Journal of Obstetrics and Gynecology
American Journal of Obstetrics and Gynecology, 2021, 225 (1), pp.51.e1-51.e17. ⟨10.1016/j.ajog.2021.01.014⟩
American journal of obstetrics and gynecology, 225(1), 51.e1-51.e17. Mosby Inc.
Schrijver, L H, Antoniou, A C, Olsson, H, Mooij, T M, Roos-Blom, M J, Azarang, L, Adlard, J, Ahmed, M, Barrowdale, D, Davidson, R, Donaldson, A, Eeles, R, Evans, D G, Frost, D, Henderson, A, Izatt, L, Ong, K R, Bonadona, V, Coupier, I, Faivre, L, Fricker, J P, Gesta, P, van Engelen, K, Jager, A, Menko, F H, Mourits, M J E, Singer, C F, Tan, Y Y, Foretova, L, Navratilova, M, Schmutzler, R K, Ellberg, C, Gerdes, A M, Caldes, T, Simard, J, Olah, E, Jakubowska, A, Rantala, J, Osorio, A, Hopper, J L, Phillips, K A, Milne, R L, Beth Terry, M, Noguès, C, Engel, C, Kast, K, Goldgar, D E, van Leeuwen, F E, Easton, D F, Andrieu, N, Rookus, M A & Epidemiological Study of Familial Breast Cancer, Gene Etude Prospective Sein Ovaire Sein, Hereditary Breast and Ovarian Cancer Research Group Netherlands, and International BRCA1/2 Carrier Cohort Study 2021, ' Oral contraceptive use and ovarian cancer risk for BRCA1/2 mutation carriers : an international cohort study ', American Journal of Obstetrics and Gynecology, vol. 225, no. 1, pp. 51.e1-51.e17 . https://doi.org/10.1016/j.ajog.2021.01.014
EMBRACE, GENEPSO, HEBON, IBCCS & et al. 2021, ' Oral contraceptive use and ovarian cancer risk for BRCA1/2 mutation carriers: an international cohort study ', American Journal of Obstetrics and Gynecology . https://doi.org/10.1016/j.ajog.2021.01.014
American Journal of Obstetrics and Gynecology, 225, 1, pp. 51.e1-51.e17
Epidemiological Study of Familial Breast Cancer, Gene Etude Prospective Sein Ovaire Sein, Hereditary Breast and Ovarian Cancer Research Group Netherlands, and International BRCA1/2 Carrier Cohort Study 2021, ' Oral contraceptive use and ovarian cancer risk for BRCA1/2 mutation carriers : an international cohort study ', American Journal of Obstetrics and Gynecology, vol. 225, no. 1, pp. 51.e1-51.e17 . https://doi.org/10.1016/j.ajog.2021.01.014
American Journal of Obstetrics and Gynecology, 225, 51.e1-51.e17
American Journal of Obstetrics and Gynecology, 225(1), 51.e1-51.e17. Mosby Inc.
American Journal of Obstetrics and Gynecology
American Journal of Obstetrics and Gynecology, 2021, 225 (1), pp.51.e1-51.e17. ⟨10.1016/j.ajog.2021.01.014⟩
American journal of obstetrics and gynecology, 225(1), 51.e1-51.e17. Mosby Inc.
Schrijver, L H, Antoniou, A C, Olsson, H, Mooij, T M, Roos-Blom, M J, Azarang, L, Adlard, J, Ahmed, M, Barrowdale, D, Davidson, R, Donaldson, A, Eeles, R, Evans, D G, Frost, D, Henderson, A, Izatt, L, Ong, K R, Bonadona, V, Coupier, I, Faivre, L, Fricker, J P, Gesta, P, van Engelen, K, Jager, A, Menko, F H, Mourits, M J E, Singer, C F, Tan, Y Y, Foretova, L, Navratilova, M, Schmutzler, R K, Ellberg, C, Gerdes, A M, Caldes, T, Simard, J, Olah, E, Jakubowska, A, Rantala, J, Osorio, A, Hopper, J L, Phillips, K A, Milne, R L, Beth Terry, M, Noguès, C, Engel, C, Kast, K, Goldgar, D E, van Leeuwen, F E, Easton, D F, Andrieu, N, Rookus, M A & Epidemiological Study of Familial Breast Cancer, Gene Etude Prospective Sein Ovaire Sein, Hereditary Breast and Ovarian Cancer Research Group Netherlands, and International BRCA1/2 Carrier Cohort Study 2021, ' Oral contraceptive use and ovarian cancer risk for BRCA1/2 mutation carriers : an international cohort study ', American Journal of Obstetrics and Gynecology, vol. 225, no. 1, pp. 51.e1-51.e17 . https://doi.org/10.1016/j.ajog.2021.01.014
EMBRACE, GENEPSO, HEBON, IBCCS & et al. 2021, ' Oral contraceptive use and ovarian cancer risk for BRCA1/2 mutation carriers: an international cohort study ', American Journal of Obstetrics and Gynecology . https://doi.org/10.1016/j.ajog.2021.01.014
American Journal of Obstetrics and Gynecology, 225, 1, pp. 51.e1-51.e17
Contains fulltext : 237895.pdf (Publisher’s version ) (Open Access) BACKGROUND: Ovarian cancer risk in BRCA1 and BRCA2 mutation carriers has been shown to decrease with longer duration of oral contraceptive use. Although the effects of using oral c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::679a56d0abad49f333383dc486d3e8ab
http://www.ajog.org/article/S0002937821000387/pdf
http://www.ajog.org/article/S0002937821000387/pdf
Autor:
Vivianne C. G. Tjan-Heijnen, Christine E. M. de Die-Smulders, C. Marleen Kets, Beppy Caanen, Jan C. Oosterwijk, Luc J.M. Smits, Lieske H. Schrijver, Matti A. Rookus, I.A.P. Derks-Smeets, Lizet E. van der Kolk, Encarna B. Gomez Garcia, Margriet Collée, Margreet G. E. M. Ausems, Christi J. van Asperen, Theo A. M. van Os, Flora E. van Leeuwen, Ron J. T. van Golde, Klaartje van Engelen
Publikováno v:
British journal of cancer, 119(3), 357-363. Nature Publishing Group
British Journal of Cancer
British Journal of Cancer, 119(3), 357-363. Nature Publishing Group
British Journal of Cancer, 119, 357-363
HEBON 2018, ' Ovarian stimulation for IVF and risk of primary breast cancer in BRCA1/2 mutation carriers ', British Journal of Cancer, vol. 119, no. 3, pp. 357-363 . https://doi.org/10.1038/s41416-018-0139-1
British Journal of Cancer, 119, 3, pp. 357-363
British Journal of Cancer, 119(3), 357-363
British Journal of Cancer
British Journal of Cancer, 119(3), 357-363. Nature Publishing Group
British Journal of Cancer, 119, 357-363
HEBON 2018, ' Ovarian stimulation for IVF and risk of primary breast cancer in BRCA1/2 mutation carriers ', British Journal of Cancer, vol. 119, no. 3, pp. 357-363 . https://doi.org/10.1038/s41416-018-0139-1
British Journal of Cancer, 119, 3, pp. 357-363
British Journal of Cancer, 119(3), 357-363
BACKGROUND: The effect of in vitro fertilisation (IVF) on breast cancer risk for BRCA1/2 mutation carriers is rarely examined. As carriers may increasingly undergo IVF as part of preimplantation genetic diagnosis (PGD), we examined the impact of ovar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a0c5b52fcec17e9ead3790890e98477a
https://doi.org/10.1038/s41416-018-0139-1
https://doi.org/10.1038/s41416-018-0139-1
Autor:
Nadine Andrieu, K-A Phillips, Christoph Engel, Doug Easton, RL Milne, Matti A. Rookus, F.E. van Leeuwen, J. L. Hopper, T.M. Mooij, M-B Terry, M-J Roos-Blom, Lieske H. Schrijver, Karin Kast, Henrik Olsson, A C Antoniou, David E. Goldgar
Publikováno v:
Cancer Research. 77:P5-08
This abstract was withdrawn by the authors.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b54f502e8c16d600878d7a46119a5971
https://doi.org/10.1158/1538-7445.sabcs16-p5-08-09
https://doi.org/10.1158/1538-7445.sabcs16-p5-08-09
Autor:
Christian F. Singer, Louise Izatt, Yen Y. Tan, Emmanuelle Mouret-Fourme, Embrace, Genepso, Bcfr, Hebon, kConFab, Marie Navratilova, Lucy Side, Trinidad Caldés, Rosemarie Davidson, Kelly-Anne Phillips, Saundra S. Buys, Dominique Leroux, Mary B. Daly, Melissa C. Southey, Marian J.E. Mourits, Brita Arver, Theo A. M. van Os, Anne-Marie Gerdes, Douglas F. Easton, Marie-José Roos-Blom, Michael Friedlander, Lieske H. Schrijver, David E. Goldgar, Anna Jakubowska, Roger L. Milne, Håkan Olsson, Lisa Walker, Ros Eeles, Flora E. van Leeuwen, Mary Porteous, Sue-Anne McLachlan, Pascaline Berthet, Lenka Foretova, Catherine Noguès, Matti A. Rookus, Debra Frost, Daniel Barrowdale, Esther M. John, Julian Adlard, Encarna B. Gomez Garcia, Nadine Andrieu, Laurence Venat-Bouvet, Anita Bane, John L. Hopper, Mary Beth Terry, Jacques Simard, Ana Osorio, Antonis C. Antoniou, Christoph Engel, Wendy K. Chung, Karin Kast, Ibccs, D. Gareth Evans, Valérie Bonadona, Edith Olah, Steve Ellis, Christi J. van Asperen, T.M. Mooij
Publikováno v:
JNCI cancer spectrum, 2(2). Oxford University Press
JNCI Cancer Spectrum
JNCI Cancer Spectrum, Oxford University Press, 2021, 2 (2), pky023. ⟨10.1093/jncics/pky023⟩
EMBRACE Investigators, GENEPSO, BCFR, HEBON, kConFab, IBCCS, & Evans, D G 2018, ' Oral contraceptive use and breast cancer risk: retrospective and prospective analyses from a BRCA1 and BRCA2 mutation carrier cohort study ', JNCI Cancer spectrum, vol. 2, no. 2 . https://doi.org/10.1093/jncics/pky023
JNCI Cancer Spectrum, 2021, 2 (2), pky023. ⟨10.1093/jncics/pky023⟩
JNCI Cancer Spectrum, 2(2):023. Oxford University Press
JNCI cancer spectrum, 2(2):pky023. Oxford University Press
JNCI Cancer Spectrum
JNCI Cancer Spectrum, Oxford University Press, 2021, 2 (2), pky023. ⟨10.1093/jncics/pky023⟩
EMBRACE Investigators, GENEPSO, BCFR, HEBON, kConFab, IBCCS, & Evans, D G 2018, ' Oral contraceptive use and breast cancer risk: retrospective and prospective analyses from a BRCA1 and BRCA2 mutation carrier cohort study ', JNCI Cancer spectrum, vol. 2, no. 2 . https://doi.org/10.1093/jncics/pky023
JNCI Cancer Spectrum, 2021, 2 (2), pky023. ⟨10.1093/jncics/pky023⟩
JNCI Cancer Spectrum, 2(2):023. Oxford University Press
JNCI cancer spectrum, 2(2):pky023. Oxford University Press
Background For BRCA1 and BRCA2 mutation carriers, the association between oral contraceptive preparation (OCP) use and breast cancer (BC) risk is still unclear. Methods Breast camcer risk associations were estimated from OCP data on 6030 BRCA1 and 38
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::753be79ab5051dc8af8808db94529a4b
https://pure.amc.nl/en/publications/oral-contraceptive-use-and-breast-cancer-risk(b6082b00-b685-43ee-a278-be969d1f1197).html
https://pure.amc.nl/en/publications/oral-contraceptive-use-and-breast-cancer-risk(b6082b00-b685-43ee-a278-be969d1f1197).html
Publikováno v:
Current Breast Cancer Reports. 6:121-131
Risks of breast and ovarian cancer among BRCA1/2 mutation carriers are high, even for the young. Recommendations for use of exogenous hormones designed for BRCA1/2 mutation carriers may therefore be appropriate. Here we review studies on the associat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b463d06b5737d690042bdd36a0aceac8
https://doi.org/10.1007/s12609-014-0145-0
https://doi.org/10.1007/s12609-014-0145-0
Autor:
Theodora C. van Tilborg, Theo A. M. van Os, Helena C. van Doorn, Anouk Pijpe, Muriel A. Adank, Matti A. Rookus, Wendy A. G. van Zelst-Stams, Senno Verhoef, Margreet G. E. M. Ausems, Christi J. van Asperen, Encarna B. Gomez Garcia, T.M. Mooij, Jan C. Oosterwijk, Anna M. E. Bos, Frank J.M. Broekmans, Lieske H. Schrijver
Publikováno v:
van Tilborg, T C, Broekmans, F J, Pijpe, A, Schrijver, L H, Mooij, T M, Oosterwijk, J C, Verhoef, S, Gómez Garcia, E B, van Zelst-Stams, W A, Adank, M A, van Asperen, C J, Van Doorn, H C, van Os, T A, Bos, A M, Rookus, M A & Ausems, M G 2016, ' Do BRCA1/2 mutation carriers have an earlier onset of natural menopause? ', Menopause, vol. 23, no. 8, pp. 903-10 . https://doi.org/10.1097/GME.0000000000000633
Menopause (New York, N.Y.), 23(8), 903-910. Lippincott Williams and Wilkins
Menopause-the Journal of the North American Menopause Society, 23(8), 903-910. LIPPINCOTT WILLIAMS & WILKINS
Menopause, 23(8), 903-10. Lippincott Williams and Wilkins
Menopause, 23(8), 903-910
Menopause. The Journal of the North American Menopause Society, 23(8), 903-910. Lippincott Williams & Wilkins
Menopause, 23(8), 903. Lippincott Williams and Wilkins
Menopause-The Journal of the North American Menopause Society, 23, 903-10
Menopause-The Journal of the North American Menopause Society, 23, 8, pp. 903-10
Menopause (New York, N.Y.), 23(8), 903-910. Lippincott Williams and Wilkins
Menopause-the Journal of the North American Menopause Society, 23(8), 903-910. LIPPINCOTT WILLIAMS & WILKINS
Menopause, 23(8), 903-10. Lippincott Williams and Wilkins
Menopause, 23(8), 903-910
Menopause. The Journal of the North American Menopause Society, 23(8), 903-910. Lippincott Williams & Wilkins
Menopause, 23(8), 903. Lippincott Williams and Wilkins
Menopause-The Journal of the North American Menopause Society, 23, 903-10
Menopause-The Journal of the North American Menopause Society, 23, 8, pp. 903-10
Contains fulltext : 168797.pdf (Publisher’s version ) (Closed access) OBJECTIVE: It has been hypothesized that BRCA1/2 mutation carriers have an earlier age at natural menopause (ANM), although to date findings are inconclusive. This study assessed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::89d6ed6f58f2d1c0b9f98428e4dc78ef
https://research.vumc.nl/en/publications/119227c2-56e3-47a3-90c3-649f516843e7
https://research.vumc.nl/en/publications/119227c2-56e3-47a3-90c3-649f516843e7
Autor:
T.M. Mooij, Nadine Andrieu, Floor E. van Leeuwen, Marie-Jose Blom, Karin Kast, Douglas F. Easton, John L. Hopper, David E. Goldgar, M. B. Terry, Christoph Engel, Roger L. Milne, Matti A. Rookus, Kelly A Phillips, Lieske H. Schrijver, Antonis C. Antoniou, Håkan Olsson
Publikováno v:
Cancer Research. 77:4276-4276
Background: BRCA1 and BRCA2 mutation carriers are at high risk of breast and ovarian cancer. Oral contraceptive preparations (OCPs) may reduce ovarian cancer risk, but its effect on breast cancer risk remains unclear. Methods: Combined data from thre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b8f4ef9db578c74b9575e0313a411a9d
https://doi.org/10.1158/1538-7445.am2017-4276
https://doi.org/10.1158/1538-7445.am2017-4276
Autor:
Leonardus W. J. E. Beurskens, Régine P.M. Steegers-Theunissen, Mark F. Wildhagen, Jan Lindemans, Dick Tibboel, Jeanne H.M. de Vries, Maarten F. C. M. Knapen, Lieske H. Schrijver
Publikováno v:
Birth Defects Res. Part A-Clin. Mol. Teratol. 97 (2013) 1
Birth Defects Res. Part A-Clin. Mol. Teratol., 97(1), 60-66
Birth Defects Research Part A-Clinical and Molecular Teratology, 97(1), 60-66. Wiley-Liss Inc.
Birth Defects Res. Part A-Clin. Mol. Teratol., 97(1), 60-66
Birth Defects Research Part A-Clinical and Molecular Teratology, 97(1), 60-66. Wiley-Liss Inc.
BACKGROUND Vitamin A has been related to the etiology of congenital diaphragmatic hernia (CDH). We performed a case-control study to investigate whether maternal dietary vitamin A intake is related to CDH in the offspring. METHODS Thirty-one pregnanc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::41f1337bd1777d2c81e2f50e81e570c5
https://research.wur.nl/en/publications/dietary-vitamin-a-intake-below-the-recommended-daily-intake-durin
https://research.wur.nl/en/publications/dietary-vitamin-a-intake-below-the-recommended-daily-intake-durin
Publikováno v:
European Journal of Cancer. 48:S75
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d8236d5dc057244c277d8b4c1b8e4b63
https://doi.org/10.1016/s0959-8049(12)70188-0
https://doi.org/10.1016/s0959-8049(12)70188-0